Crossref


3. A clinical case of non-alcoholic fatty liver disease with polycystic ovary syndrome

- L.A. Dudareva

- A.V. Tkachev

- A.M. Aslanov

- G.N. Tarasova

- V.A. Kosenko

- K.E. Mazovka

- E.N. Veselova

- L.S. Mkrtchyan

- L.V. Sudyina

- Yu.Yu. Chebotareva

4. A circulating microRNA signature as noninvasive diagnostic and prognostic biomarkers for nonalcoholic steatohepatitis

- Jie Liu

- Yue Xiao

- Xikun Wu

- Lichun Jiang

- Shurong Yang

- Zhiming Ding

- Zhuo Fang

- Haiqing Hua

- Mark Stephen Kirby

- Jianyong Shou

5. Clinical and Laboratory Characteristics of Normal Weight and Obese Individuals with Non-Alcoholic Fatty Liver Disease

- Anca Trifan

- Adrian Rotaru

- Remus Stafie

- Ermina Stratina

- Sebastian Zenovia

- Robert Nastasa

- Laura Huiban

- Tudor Cuciureanu

- Cristina Muzîca

- Stefan Chiriac

- Irina Gîrleanu

- Ana-Maria Sîngeap

- Catalin Sfarti

- Camelia Cojocariu

- Carol Stanciu

6. Is Aspartate Aminotransferase to Platelet Ratio Index a Better Noninvasive Score for Predicting Advanced Fibrosis in Nonalcoholic Fatty Liver Disease Patients?

- Priyansh D Bhayani

- Sarojini A Parameswaran

- Kallippatti R Palaniswamy

- Paramasivan Piramanayagam

- Natarajan Murugan

7. Serum proteome assessment in nonalcoholic fatty liver disease in children: a preliminary study

- Paweł Małecki

- Joanna Tracz

- Magdalena Łuczak

- Magdalena Figlerowicz

- Katarzyna Mazur-Melewska

- Wojciech Służewski

- Anna Mania

9. High FIB4 index is an independent risk factor of diabetic kidney disease in type 2 diabetes

- Haruka Saito

- Hayato Tanabe

- Akihiro Kudo

- Noritaka Machii

- Moritake Higa

- Satoshi Yamaguchi

- Gulinu Maimaituxun

- Kazumichi Abe

- Atsushi Takahashi

- Kenichi Tanaka

- Koichi Asahi

- Hiroaki Masuzaki

- Hiromasa Ohira

- Junichiro J. Kazama

- Michio Shimabukuro

10. Diagnostic Accuracy of FIB-4 and FIB-5 Scores as Compared to Fibroscan for Assessment of Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease

- Bandana Kumari

- Ramesh Kumar

- Sadhana Sharma

- Ayan Banerjee

- Visesh Kumar

- Pawan Kumar

- Neha Chaudhary

- Sushil Kumar

- Khushboo Raj

11. Modeling the progression of NAFLD: a multi-state Markov approach based on BMI classification in the Chinese population

- Jianmin Tang

- Halengbieke Aheyeerke

- Chao Tong

- Xuetong Ni

- Tengrui Cao

- Yumei Han

- Shuo Chen

- Linrun Kong

- Xinghua Yang

12. Liver Stiffness Measurement by Using Transient Elastography in Bangladeshi Patients with Type 2 Diabetes Mellitus and Ultrasonography-Diagnosed Nonalcoholic Fatty Liver Disease

- Muhammad Shah Alam

- ABM Kamrul-Hasan

- Syeda Tanzina Kalam

- SM Mizanur Rahman

- Mohammad Izazul Hoque

- Md. Belalul Islam

- Ajit Kumar Paul

14. Elevated liver stiffness without histological evidence of liver fibrosis in rural Ugandans

- Martin Tibuakuu

- Caroline Jjingo

- Gregory Dale Kirk

- David Lee Thomas

- Ronald Gray

- Victor Ssempijja

- Fred Nalugoda

- David Serwadda

- Ponsiano Ocama

- Christopher Kenneth Opio

- David Erwin Kleiner

- Thomas Charles Quinn

- Steven James Reynolds

16. Liver Stiffness Measurement is Useful in Predicting Type 2 Diabetes Mellitus Among Nonalcohol Fatty Liver Disease Patients

- Yuping Ding

- Guiqiang Wang

- Quanjun Deng

- Mei Yang

- Jinghua Li

- Zuoyu Wang

- Haiyan Niu

- Shihai Xia

17. Efficacy of Lipid Ratios and Platelet Distribution Width for Assessment of Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease

- Bandana Kumari

- Sadhana Sharma

- Ramesh Kumar

- Satish Dipankar

- Bijaya N Naik

- Ayan Banerjee

- Sushil Kumar

19. Marine Chitooligosaccharide Alters Intestinal Flora Structure and Regulates Hepatic Inflammatory Response to Influence Nonalcoholic Fatty Liver Disease

- Jiayao Feng

- Yongjian Liu

- Jiajia Chen

- Yan Bai

- Jincan He

- Hua Cao

- Qishi Che

- Jiao Guo

- Zhengquan Su

20. Beneficial Effects of Tamarind Trypsin Inhibitor in Chitosan–Whey Protein Nanoparticles on Hepatic Injury Induced High Glycemic Index Diet: A Preclinical Study

- Ana J. F. C. Aguiar

- Jaluza L. C. de Queiroz

- Pedro P. A. Santos

- Christina S. Camillo

- Alexandre C. Serquiz

- Izael S. Costa

- Gerciane S. Oliveira

- Ana F. T. Gomes

- Lídia L. R. Matias

- Rafael O. A. Costa

- Thaís S. Passos

- Ana H. A. Morais

21. Predictors of Hepatic Fibrosis in Type 2 Diabetes Patients with Metabolic-Dysfunction-Associated Steatotic Liver Disease

- Joana D’Arc Matos França de Abreu

- Rossana Sousa Azulay

- Vandilson Rodrigues

- Sterffeson Lamare Lucena de Abreu

- Maria da Glória Tavares

- Flávia Coelho Mohana Pinheiro

- Clariano Pires de Oliveira Neto

- Caio Andrade

- Alexandre Facundo

- Adriana Guimarães

- Patrícia Ribeiro Azevedo

- Ana Gregória Pereira de Almeida

- Debora Camelo de Abreu Costa

- Rogério Soares Castro

- Marcelo Magalhães

- Gilvan Cortês Nascimento

- Manuel dos Santos Faria

- Adalgisa de Souza Paiva Ferreira

23. Liver Fibrosis Biomarker Validation Using Machine Learning Algorithms

- Min-Kyeong Kim

- Heon-Ju Kwon

- Kangsu Shin

- Hyosoon Park

- Hee-Yeon Woo

- Chang-Hun Park

- Min-Jung Kwon

24. FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH

- Laura Martínez‐Arenas

- Carmen Vinaixa

- Isabel Conde

- Sara Lorente

- Fernando Díaz‐Fontenla

- Patrice Marques

- Judith Pérez‐Rojas

- Eva Montalvá

- Ângela Carvalho‐Gomes

- Marina Berenguer

26. Phase angle as a severity indicator for liver diseases

- Ana Paula Pagano

- Juliana Maria Faccioli Sicchieri

- Isabela Laurencio Schiavoni

- Daniel Barbeiro

- Camila Sanches Manca

- Bruna Ramos da Silva

- Amanda Escobar Bezerra

- Lívia Cristina Mendonça Pinto

- Roberta Chaves Araújo

- Andreza Correa Teixeira

- Paula Garcia Chiarello

28. Liver Fibrosis Index-4 Does Not Correlate to Liver Elastography in Patients with Inflammatory Bowel Disease

- Iván Ferraz-Amaro

- Alejandro Hernández-Camba

- Marta Carrillo-Palau

- Noemi Hernández Álvarez-Buylla

- Antonia de Vera-González

- Alejandra González-Delgado

- Elena Heras-Recuero

- Miguel Á. González-Gay

29. Impact of Liver Fibrosis and Fatty Liver on T1rho Measurements: A Prospective Study

- Shuangshuang Xie

- Qing Li

- Yue Cheng

- Yu Zhang

- Zhizheng Zhuo

- Guiming Zhao

- Wen Shen

31. The Fibrosis-4 Index Is Useful for Predicting Mortality in Patients with Pulmonary Hypertension due to Left Heart Disease

- Tetsuro Yokokawa

- Koichi Sugimoto

- Akiomi Yoshihisa

- Takuya Goto

- Tomofumi Misaka

- Masayoshi Oikawa

- Atsushi Kobayashi

- Takayoshi Yamaki

- Hiroyuki Kunii

- Kazuhiko Nakazato

- Takafumi Ishida

- Yasuchika Takeishi

33. Effects of TM6SF2 rs58542926 polymorphism on hepatocellular lipids and insulin resistance in early type 2 diabetes

- Kálmán Bódis

- Maria Bombrich

- Martin Schön

- Birgit Knebel

- Oana-Patricia Zaharia

- Gidon Bönhof

- Yanislava Karusheva

- Klaus Strassburger

- Yuliya Kupriyanova

- Jörg Kotzka

- Rainer Guthoff

- Vera Schrauwen-Hinderling

- Hadi Al-Hasani

- Volker Burkart

- Julia Szendroedi

- Robert Wagner

- Daniel F. Markgraf

- Michael Roden

34. Platelet Proteomics: A Glimpse Into Metabolic Dysfunction‐Associated Steatotic Liver Disease Pathogenesis

- Iulia Minciuna

- Maria Iacobescu

- Ioana Rusu

- Oana Nicoara‐Farcau

- Petra Fischer

- Andreea Maria Soporan

- Ioana Ecaterina Pralea

- Horia Stefanescu

- Cristina Adela Iuga

- Bogdan Procopet

37. Transcriptome analysis reveals the molecular mechanism of Yiqi Rougan decoction in reducing CCl4-induced liver fibrosis in rats

- Yu Xiong

- Jinyuan Hu

- Chen Xuan

- Jiayu Tian

- Kaiyue Tan

- Zhiwei Chen

- Yan Luo

- Xuqin Du

- Junxiong Cheng

- Lanyue Zhang

- Wenfu Cao

41. Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers

- Stephen A. Harrison

- Salvatore Calanna

- Kenneth Cusi

- Martin Linder

- Takeshi Okanoue

- Vlad Ratziu

- Arun Sanyal

- Anne-Sophie Sejling

- Philip N. Newsome

42. Platelet-derived growth factor receptor-β as a non-invasive biomarker for liver fibrosis prediction in Egyptian diabetic patients with metabolic-associated fatty liver disease

- Hanaa Badran

- Maha Elsabaawy

- Mai Magdy

- Hazem Omar

- Olfat Hendy

- Eman Awaad

- Maymona Abd El-Wahed Al-Khalifa

- Mai Abozeid